Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study

This publication has 30 references indexed in Scilit:

• Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
  The Lancet, 2016
• Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy
  Published by Elsevier ,2015
• Immune Checkpoint Blockade in Cancer Therapy
  Journal of Clinical Oncology, 2015
• Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery
  Statistical Methods in Medical Research, 2011
• CT60 and +49 polymorphisms of CTLA 4 are associated with ANCA-positive small vessel vasculitis
  Rheumatology, 2009
• Relation of Acute Pericardial Disease to Malignancy
  Published by Elsevier ,2005
• Risk factors for visual loss in an Italian population‐based cohort of patients with giant cell arteritis
  Arthritis Care & Research, 2005
• Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death
  European Heart Journal, 2005
• The reporting odds ratio and its advantages over the proportional reporting ratio
  Pharmacoepidemiology and Drug Safety, 2004
• Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
  Science, 2001